Fundraising Fox
Digital Bio
18 known investors
Find your way into Digital Bio
Sign up to find every way you can get introduced to Digital Bio
- Your email: who you already know at Digital Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Digital Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
Investors · 18
How we know: Fifty Years's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: techcrunch.com · Not right? Tell us
Also in the syndicate · 11
Funding
SEC filings, press & company announcements$3M disclosed across 1 of 3 rounds · 2024–2026
- $3MraisedMar 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Digital Bio do?
- Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
- Who are Digital Bio's investors?
- Digital Bio's investors include Fifty Years, A91 Partners, Goldman Sachs, HSBC, Morgan Stanley, Peak XV Partners, Steadview Capital.
- How much funding has Digital Bio raised?
- Digital Bio has disclosed $3M raised across 1 of its 3 known rounds.